-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, P1HGtaIOcr9CEq2ZxRHliZ4btVNqL/21rxkMzvlgoNtEo+dUDW79tn1T8Lt9C3fv 9HZbEJ+8bFWBIFbUuMF9BA== 0001193125-08-028932.txt : 20080213 0001193125-08-028932.hdr.sgml : 20080213 20080213130828 ACCESSION NUMBER: 0001193125-08-028932 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20080213 DATE AS OF CHANGE: 20080213 GROUP MEMBERS: S-YANGTSE HOLDINGS LIMITED SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: TONGJITANG CHINESE MEDICINES CO CENTRAL INDEX KEY: 0001386608 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-83729 FILM NUMBER: 08603032 BUSINESS ADDRESS: STREET 1: 5/F BLK B, BAIYING MEDICAL DEVICE PARK STREET 2: NANHAI AVENUE SOUTH, NANSHAN DISTRICT CITY: SHENZHEN, GUANGDONG STATE: F4 ZIP: 518067 BUSINESS PHONE: (86-755) 2667-0969 MAIL ADDRESS: STREET 1: 5/F BLK B, BAIYING MEDICAL DEVICE PARK STREET 2: NANHAI AVENUE SOUTH, NANSHAN DISTRICT CITY: SHENZHEN, GUANGDONG STATE: F4 ZIP: 518067 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: WANG SHAOLAN CENTRAL INDEX KEY: 0001425948 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: BUSINESS PHONE: (86-755) 2689-1550 MAIL ADDRESS: STREET 1: 5/F., BLK B, BAIYING MEDICAL DEVICE PARK STREET 2: NANHAI AVENUE SOUTH, NANSHAN DISTRICT CITY: SHENZHEN, GUANGDONG STATE: F4 ZIP: 518067 SC 13G 1 dsc13g.htm SCHEDULE 13G Schedule 13G

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934

(Amendment No.     )*

 

 

 

 

Tongjitang Chinese Medicines Company

(Name of Issuer)

 

 

Ordinary Shares

(Title of Class of Securities)

 

 

G8918E106

(CUSIP Number)

 

 

December 31, 2007

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

 

 

*   The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. G8918E106   13G   Page 2 of 6 Pages

 

  1  

NAME OF REPORTING PERSON

 

            Shaolan Wang

    
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨

(b)  x

    
  3  

SEC USE ONLY

 

    
  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            People’s Republic of China

    

 

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

  

  5    SOLE VOTING POWER

 

            9,548,000 ordinary shares (including 400,000 ordinary shares issuable upon exercise of options within 60 days after December 31, 2007)

 

  6    SHARED VOTING POWER

 

            0

 

  7    SOLE DISPOSITIVE POWER

 

            9,548,000 ordinary shares (including 400,000 ordinary shares issuable upon exercise of options within 60 days after December 31, 2007)

 

  8    SHARED DISPOSITIVE POWER

 

            0

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

            9,548,000 ordinary shares

    
10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

  

¨

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

            7.03%

    
12  

TYPE OF REPORTING PERSON*

 

            IN

    

CUSIP No. G8918E106   13G   Page 3 of 6 Pages

 

  1  

NAME OF REPORTING PERSON

 

            S-Yangtse Holdings Limited

   
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨

(b)  x

    
  3  

SEC USE ONLY

 

    
  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            British Virgin Islands

    

 

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

  

  5    SOLE VOTING POWER

 

            8,748,000 ordinary shares. (Shaolan Wang may also be deemed to have sole voting power with respect to these ordinary shares.)

 

  6    SHARED VOTING POWER

 

            0

 

  7    SOLE DISPOSITIVE POWER

 

            8,748,000 ordinary shares. (Shaolan Wang may also be deemed to have sole voting power with respect to these ordinary shares.)

 

  8    SHARED DISPOSITIVE POWER

 

            0

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

            8,748,000 ordinary shares

    
10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

  

¨

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

            6.46%

    
12  

TYPE OF REPORTING PERSON*

 

            CO

    

CUSIP No. G8918E106   13G   Page 4 of 6 Pages

 

ITEM 1  

(a).

    NAME OF ISSUER:      
     Tongjitang Chinese Medicines Company      
ITEM 1  

(b).

    ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES:      
    

5th Floor, Block B, Baiying Medical Device Park,

Nanhai Avenue South, Nanshan District,

Shenzhen, Guangdong Province 518067,

People’s Republic of China

      
ITEM 2  

(a).

    NAME OF PERSON FILING:      
    

Shaolan Wang

S-Yangtse Holdings Limited

     
ITEM 2  

(b).

    ADDRESS OF PRINCIPAL BUSINESS OFFICE, OR, IF NONE, RESIDENCE:      
    

Shaolan Wang

c/o Tongjitang Chinese Medicines Company

5th Floor, Block B, Baiying Medical Device Park,

Nanhai Avenue South, Nanshan District,

Shenzhen, Guangdong Province 518067,

People’s Republic of China

      
    

S-Yangtse Holdings Limited

Pasea Estate, Road Town

Tortola

British Virgin Islands

      
ITEM 2  

(c).

    CITIZENSHIP:      
    

Shaolan Wang – PRC

 

S-Yangtse Holdings Limited – British Virgin Islands

      
ITEM 2  

(d).

    TITLE OF CLASS OF SECURITIES:      
     Ordinary Shares      
ITEM 2  

(e).

    CUSIP NUMBER:      
     G8918E106      
ITEM 3.   Not Applicable      

CUSIP No. G8918E106   13G   Page 5 of 6 Pages

 

ITEM 4.    OWNERSHIP:         
   The following information with respect to the ownership of the ordinary shares, with a par value of US$0.001 per share, of the Issuer by each of the reporting persons is provided as of December 31, 2007:         

 

Reporting Person

    Amount
beneficially
owned:		    Percent
of class:		    Sole
power to
vote or
direct
the vote:		    Shared
power to
vote or to
direct
the vote:		    Sole power to
dispose or to
direct the
disposition of:		    Shared power
to dispose or to
direct the
disposition of:

Shaolan Wang

    9,548,000    7.03    9,548,000    0    9,548,000    0

S-Yangtse Holdings Limited

    8,748,000    6.46    8,748,000    0    8,748,000    0

 

  

S-Yangtse Holdings Limited, a British Virgin Islands company, is the record owner of 8,748,000 ordinary shares of the Issuer. S-Yangtse Holdings Limited is wholly owned and controlled by Shaolan Wang. Pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules promulgated thereunder, Shaolan Wang may be deemed to beneficially own all of these 8,748,000 ordinary shares held by S-Yangtse Holdings Limited.

 

In addition, Shaolan Wang is the record holder of 400,000 ordinary shares of the Issuer and has right to acquire 400,000 ordinary shares of the Issuer upon exercise of options within 60 days after December 31, 2007. As a result, Shaolan Wang is deemed to beneficially own an aggregate of 9,548,000 ordinary shares of the Issuer.

         
ITEM 5.    OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:   
   Not applicable   
ITEM 6.    OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:         
   Not applicable         
ITEM 7.    IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY:
   Not applicable
ITEM 8.    IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:         
   Not applicable         
ITEM 9.    NOTICE OF DISSOLUTION OF GROUP:         
   Not applicable         
ITEM 10.    CERTIFICATION:         
   Not applicable         

CUSIP No. G8918E106   13G   Page 6 of 6 Pages

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 13, 2008

 

Shaolan Wang  

/s/ Shaolan Wang

  Shaolan Wang
S-Yangtse Holdings Limited   By:  

/s/ Shaolan Wang

  Name:   Shaolan Wang
  Title:   Director

LIST OF EXHIBITS

 

Exhibit No.

   

Description

A

    Joint Filing Agreement
 EX-99.(A) 2 dex99a.htm JOINT FILING AGREEMENT Joint Filing Agreement

EXHIBIT A: Joint Filing Agreement

In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the ordinary shares, par value $0.001 per share, of Tongjitang Chinese Medicines Company, a Cayman Islands company, and that this Agreement may be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

[Remainder of this page has been left intentionally blank.]

Signature Page

IN WITNESS WHEREOF, the undersigned hereby execute this Agreement as of February 13, 2008.

 

Shaolan Wang  

/s/ Shaolan Wang

  Shaolan Wang
S-Yangtse Holdings Limited   By:  

/s/ Shaolan Wang

  Name:   Shaolan Wang
  Title:   Director
 -----END PRIVACY-ENHANCED MESSAGE-----